Although we validated the serum decrease of apolipoprotein C-I in this group of patients with early-stage CRC, we could not use the acquired serum or tissue protein profiles as such for correct classification of CON, AP and CRC. This evidence concerns the gene APOC1 and colorectal carcinoma.